ResMed reported $294.67M in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Ansell ANN:AU USD 178.7M 32.4M
Cochlear COH:AU AUD 213M 45.8M
Estia Health EHE:AU AUD 17.69M 35.9M
Fisher & Paykel Healthcare FPH:AU NZD 246.1M 95.6M
Healius Ltd HLS:AU AUD 258.7M 249.5M
Integral Diagnostics Ltd IDX:AU AUD 36.81M 4.8M
Mayne Pharma MYX:AU AUD 4.99M 19.9M
Nanosonics Ltd NAN:AU AUD 1.3M 4.97M
Polynovo Ltd PNV:AU AUD -642440 3.17M
Ramsay Health Care RHC:AU AUD 584M 189.1M
Regis Healthcare REG:AU AUD 32.95M 43.23M
ResMed RMD:AU USD 294.67M 18.1M
Sigma Healthcare Ltd SIG:AU AUD 28.59M 5.82M
Sonic Healthcare SHL:AU AUD 1.29B 248.31M
Telix Pharmaceuticals Ltd TLX:AU AUD -66472000 22.18M